Mandate

Vinge advises DORO SAS in connection with the acquisition of all shares in French based Prylos SAS

July 12, 2011

Vinge has advised DORO SAS in connection with its acquisition of all shares in the French based company, Prylos SAS. DORO SAS is a wholly-owned subsidiary of DORO AB, the shares of which are listed on the Nordic List, Small Companies, on OMX NASDAQ Stockholm. Doro focuses on the development, marketing and sale of telecom products which are specifically directed to the elderly. With more than 35 years experience and sales in more than 30 countries on five continents, Doro is a world leading trademark within the field of simple and user-friendly mobile phones. As a result of the acquisition, Doro has acquired an Android-based platform for its product launches and a dedicated development team within telecom solutions for senior citizens.

Vinge’s team advising DORO SAS consisted of partners Johan Winnerblad and Johan Göthberg and associate Nina Farrahi. Partner Karin Grauers provided intellectual property law advice.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026